Global tuberculosis report 2013 supplement
Edward Nardell, MD Brigham & Womens Hospital Division of Global Health Equity Pulmonary Division Harvard Medical School Harvard School of Public Health.
Management of Drug-Resistant Tuberculosis Your name Institution/organization Meeting Date International Standard 15.
Management of Drug-Resistant Tuberculosis Your name Institution/organization Meeting Date International Standard 12.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Clinical Practice Guidelines for the Diagnosis, Treatment, Prevention and Control of Tuberculosis in Adult Filipinos[1]
MDR - XDR
Eng Supplement Vho2014
RNTCP: DOTS Expansion and plans for DOTS-Plus Central Tuberculosis Division Directorate General of Health Services Ministry of Health & Family Welfare.
Drug-Resistant Tuberculosis
Overview of Procurement and Supply Management Policies Meeting of WHO Prequalification Programme with European manufacturers and EU marketing authorisation.
Ongoing trials with new drugs/regimens: the fluoroquinolone case J. Grosset, E. Nuermberger & R.Chaisson Center for TB Research, Johns Hopkins University.
![Clinical Practice Guidelines for the Diagnosis, Treatment, Prevention and Control of Tuberculosis in Adult Filipinos[1]](https://static.fdocuments.net/doc/330x215/55720e9a497959fc0b8c7c8b/clinical-practice-guidelines-for-the-diagnosis-treatment-prevention-and-control-of-tuberculosis-in-adult-filipinos1.jpg)
